Cancer · 1992 · 79 citations · 20 references
MedicineCancer BiologyOncologyBreast OncologyEndocrine OncologySteroid BiochemistryBreast Cancer OncologyBreast PathologyEndocrine Tumor PathologyEndocrine Tumor PrognosisMammary TumorsAromatase ActivityAromatase ExpressionBreast Cancer PrognosisEstrogen Receptor ExpressionEstrogen Receptor StatusHormone Receptor - Positive Breast CancerProgesterone Receptor StatusProgesterone Receptors
The estrogen receptor, progesterone receptor, and intratumoral aromatase content of 127 breast carcinomas were determined. Patients whose tumor contained either estrogen or progesterone receptors had a longer disease-free interval, but no difference in survival was observed. Measurable aromatase activity was detected in 78 of 113 (69%) tumors. There was no relationship between aromatase activity and disease-free interval or survival.
20
Follow-up study of HER-2/neu amplification in primary breast cancer.
Gary M. Clark, William McGuire · PubMed · 1991 · 263 citations
Evaluation of estrogen receptor assays in human breast cancer tissue.
McGuire Wl, De La Garza M, G C Chamness · PubMed · 1977 · 202 citations
Medicine, Endocrinology, Oncology +17